BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 10473102)

  • 1. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells.
    Ye D; Mendelsohn J; Fan Z
    Clin Cancer Res; 1999 Aug; 5(8):2171-7. PubMed ID: 10473102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225.
    Ye D; Mendelsohn J; Fan Z
    Oncogene; 1999 Jan; 18(3):731-8. PubMed ID: 9989823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
    Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
    Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
    Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 ('Iressa') induces cell-cycle arrest and inhibits proliferation in prostate cancer cells.
    Sgambato A; Camerini A; Faraglia B; Ardito R; Bianchino G; Spada D; Boninsegna A; Valentini V; Cittadini A
    J Cell Physiol; 2004 Oct; 201(1):97-105. PubMed ID: 15281092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors.
    Fan Z; Shang BY; Lu Y; Chou JL; Mendelsohn J
    Clin Cancer Res; 1997 Nov; 3(11):1943-8. PubMed ID: 9815583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145.
    Peng D; Fan Z; Lu Y; DeBlasio T; Scher H; Mendelsohn J
    Cancer Res; 1996 Aug; 56(16):3666-9. PubMed ID: 8706005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
    Karashima T; Sweeney P; Slaton JW; Kim SJ; Kedar D; Izawa JI; Fan Z; Pettaway C; Hicklin DJ; Shuin T; Dinney CP
    Clin Cancer Res; 2002 May; 8(5):1253-64. PubMed ID: 12006546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody.
    Wu X; Rubin M; Fan Z; DeBlasio T; Soos T; Koff A; Mendelsohn J
    Oncogene; 1996 Apr; 12(7):1397-403. PubMed ID: 8622855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
    Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H; Nomura T; Honjo T; Tsubata T
    Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
    Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
    Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
    Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor.
    Liu XH; Wiley HS; Meikle AW
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1472-8. PubMed ID: 8263129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of p27 and cyclin D1 by TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ; Yan S; Dolce C; Kinniburgh AJ; Wenner CE
    J Cell Physiol; 1996 Sep; 168(3):510-20. PubMed ID: 8816905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.
    Lu S; Tsai SY; Tsai MJ
    Cancer Res; 1997 Oct; 57(20):4511-6. PubMed ID: 9377562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells.
    Liu XH; Kirschenbaum A; Yao S; Liu G; Aaronson SA; Levine AC
    Cancer Res; 2007 Jun; 67(12):5747-53. PubMed ID: 17575141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.